Opus Genetics, Inc.
IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31
Reports and events: 309 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-01-2416:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-001899 |
| 2025-01-2317:20 ET | 8-K | 8.01 Other events | 0001140361-25-001819 |
| 2025-01-1409:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-001013 |
| 2025-01-0717:10 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001140361-25-000467 |
| 2024-11-1209:29 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001140361-24-046045 |
| 2024-11-1208:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-046028 |
| 2024-10-2917:26 ET | SC 13D | Ownership report, active investor | 0001193125-24-246646 |
| 2024-10-2217:09 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.02 Results of operations; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-043915 |
| 2024-08-1316:06 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001140361-24-037068 |
| 2024-08-1308:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-036944 |
| 2024-06-1316:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-030012 |
| 2024-05-1016:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001140361-24-025481 |
| 2024-05-1016:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-025476 |
| 2024-05-1008:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-025329 |
| 2024-04-2916:28 ET | DEF 14A | Proxy statementPeriod 2024-06-11 | 0001140361-24-023004 |
| 2024-04-1716:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-020320 |
| 2024-03-2716:26 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-015624 |
| 2024-03-0817:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001140361-24-012399 |
| 2024-03-0808:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-24-012128 |
| 2024-02-1616:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-24-008352 |
| 2023-12-0619:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-23-056425 |
| 2023-11-2708:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-054632 |
| 2023-11-1308:48 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001140361-23-052749 |
| 2023-11-1308:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-052736 |
| 2023-11-0208:44 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-051009 |
| 2023-11-0116:21 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-050844 |
| 2023-09-2708:45 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-045418 |
| 2023-08-1109:27 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-039201 |
| 2023-08-1108:51 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001140361-23-039196 |
| 2023-08-0111:21 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-037246 |
| 2023-06-1416:31 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-23-029848 |
| 2023-06-0917:58 ET | 8-K | 5.07 Shareholder vote results | 0001140361-23-029009 |
| 2023-06-0216:30 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-23-028066 |
| 2023-05-1508:20 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001140361-23-024504 |
| 2023-05-1508:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-024502 |
| 2023-05-0116:12 ET | DEF 14A | Proxy statementPeriod 2023-06-06 | 0001140361-23-022044 |
| 2023-04-2108:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-23-019505 |
| 2023-03-3017:07 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001140361-23-014868 |
| 2023-03-3009:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-23-014674 |
| 2023-01-2516:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-23-002726 |
| 2022-12-0606:37 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-044521 |
| 2022-11-0716:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-22-040303 |
| 2022-11-0417:01 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001140361-22-040029 |
| 2022-11-0416:39 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-22-040018 |
| 2022-10-1411:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-037191 |
| 2022-08-1216:59 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001140361-22-029461 |
| 2022-08-1207:51 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-22-029352 |
| 2022-06-1716:05 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-22-023457 |
| 2022-06-1016:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-22-022593 |
| 2022-05-1907:43 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-22-019865 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:22 ET. Listed shows no prices and gives no investment advice.